Catalyst Wire Dossier Catalyst Wire Dossier

Diphtheria-tetanus-acellular Pertussis Vaccine (DTaP)

Diphtheria-tetanus-acellular pertussis vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Diphtheria-tetanus-acellular Pertussis Vaccine (DTaP), covering 2010-12-24 to 2010-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults [Phase 3]

See pricing